Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Divis Labs Chairman C Murali K Divi highest paid Indian pharma executive, Check out his Remuneration

      Divis Labs Chairman C Murali K Divi highest paid Indian pharma executive, Check out his Remuneration

      Medical Dialogues Bureau12 Aug 2019 1:13 PM IST
      New Delhi; Chairman and Managing Director of city-based pharma company C Murali K Divi is the highest paid executive of the Indian pharma industry...
      Natco Pharma to focus to scale up Cancer treatment biz in China: MD VC Nannapaneni

      Natco Pharma to focus to scale up Cancer treatment biz in China: MD VC Nannapaneni

      Medical Dialogues Bureau12 Aug 2019 12:26 PM IST
      New Delhi: Natco Pharma is focusing on filing of cancer treatment drugs in China, the world's second largest pharmaceutical market, as part of its...
      Ex-Eagle Scout accused in online drug empire to stand trial

      Ex-Eagle Scout accused in online drug empire to stand trial

      Medical Dialogues Bureau12 Aug 2019 9:28 AM IST
      SALT LAKE CITY: A 29-year-old former Eagle Scout accused of running a multimillion-dollar opioid drug ring out of his suburban Salt Lake City basement...
      Not withholding interim compensation from patients who want more: JnJ to HC

      Not withholding interim compensation from patients who want more: JnJ to HC

      Medical Dialogues Bureau11 Aug 2019 3:30 PM IST
      The government's contention was opposed by JnJ which said it had paid more people than just 67 and told the court that it will provide a list of the...
      Sterling Biotech Money Laundering Case: Relief to co-accused as Delhi HC junks ED plea to cancel bail

      Sterling Biotech Money Laundering Case: Relief to co-accused as Delhi HC junks ED plea to cancel bail

      Medical Dialogues Bureau11 Aug 2019 9:47 AM IST
      Justice Sunil Gaur said the accused deserve bail on merits and the orders granting them relief is not liable to be interfered with as the impugned...
      Strides Pharma gets zero USFDA observations for Alathur facility

      Strides Pharma gets zero USFDA observations for Alathur facility

      Medical Dialogues Bureau11 Aug 2019 9:31 AM IST
      The company's formulation facility at Alathur in Chennai underwent a United States Food and Drug Administration (USFDA) inspection from August 5 to 9,...
      Bayer mediator dismisses report of USD 8 billion Roundup settlement

      Bayer mediator dismisses report of USD 8 billion Roundup settlement

      Medical Dialogues Bureau11 Aug 2019 9:15 AM IST
      Roundup is the flagship weed-killing product of Monsanto, the American seeds and pesticides maker that Bayer bought last year in a mammoth $63 billion...
      Canada enacts drug price crackdown, in blow to pharmaceutical industry

      Canada enacts drug price crackdown, in blow to pharmaceutical industry

      Medical Dialogues Bureau11 Aug 2019 9:00 AM IST
      The changes are the biggest reform to Canada's drug price regime since 1987 and could eventually cut the earnings of drugmakers in the United States,...
      Zydus Cadila total income up by 21 percent to Rs 3496 crore in Q1

      Zydus Cadila total income up by 21 percent to Rs 3496 crore in Q1

      Medical Dialogues Bureau10 Aug 2019 12:43 PM IST
      During the quarter, Zydus Cadila entered into a marketing alliance with SIFI, the Italian leader in the development of therapeutic solutions for...
      USFDA completes inspection of Nagpur facility with no observations: Lupin

      USFDA completes inspection of Nagpur facility with no observations: Lupin

      Medical Dialogues Bureau10 Aug 2019 9:30 AM IST
      The inspection by the US Food and Drug Administration (USFDA) for a facility at Nagpur was carried out between August 5, 2019, and August 8, 2019. It...
      Chemcon Speciality Chemicals files Rs 350 crore IPO papers with SEBI

      Chemcon Speciality Chemicals files Rs 350 crore IPO papers with SEBI

      Medical Dialogues Bureau10 Aug 2019 9:30 AM IST
      The key customers of the company's pharmaceutical chemicals include Hetero Labs, Laurus Labs, Aurobindo Pharma and IndSwift Laboratories. The shares...
      Amgen wins patent battle against Novartis for blockbuster arthritis drug Enbrel

      Amgen wins patent battle against Novartis for blockbuster arthritis drug Enbrel

      Medical Dialogues Bureau10 Aug 2019 9:20 AM IST
      Enbrel generated $5.01 billion in sales for Amgen in 2018 and belongs to a class of medications known as biologics, made from living cells and are...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok